Table 1.
Comparison of clinical and biochemical indicators across the normal control and dyslipidemia groups.
| Clinical and Biochemical Indices | Group | χ2/t | p Value | |
|---|---|---|---|---|
| Normal Control | Dyslipidemia | |||
| n (Male/Female) | 764 (375/389) | 712 (354/358) | 0.060 | 0.807 |
| Age (year) | 43.60 ± 15.32 | 45.16 ± 15.08 | −1.955 | 0.051 |
| Height (cm) | 161.04 ± 8.78 | 162.17 ± 9.06 | −2.408 | 0.016 * |
| Weight (kg) | 58.68 ± 10.99 | 67.05 ± 13.87 | −12.813 | <0.001 * |
| BMI (kg/m2) | 22.55 ± 3.48 | 25.38 ± 4.20 | −14.040 | <0.001 * |
| WC (cm) | 81.23 ± 9.97 | 89.99 ± 11.90 | −15.264 | <0.001 * |
| HC (cm) | 93.84 ± 7.60 | 98.62 ± 8.49 | −11.330 | <0.001 * |
| WHR | 0.87 ± 0.07 | 0.91 ± 0.08 | −12.068 | <0.001 * |
| SBP (mmHg) | 128.68 ± 23.11 | 134.11 ± 24.08 | −4.399 | <0.001 * |
| DBP (mmHg) | 80.87 ± 13.76 | 84.30 ± 14.55 | −4.634 | <0.001 * |
| TG (mmol/L) | 0.80 ± 0.28 | 2.16 ± 1.74 | −21.397 | <0.001 * |
| TC (mmol/L) | 4.00 ± 0.71 | 4.90 ± 1.58 | −14.261 | <0.001 * |
| LDL-C (mmol/L) | 2.02 ± 0.52 | 2.73 ± 1.07 | −16.448 | <0.001 * |
| HDL-C (mmol/L) | 1.45 ± 0.29 | 1.09 ± 0.43 | 19.517 | <0.001 * |
| FPG (mmol/L) | 4.54 ± 1.28 | 4.80 ± 1.73 | −3.300 | 0.001 * |
| LPa (mg/L) | 259.51 ± 321.85 | 251.37 ± 348.31 | 0.439 | 0.661 |
| ApoA (g/L) | 1.38 ± 0.23 | 1.23 ± 0.37 | 9.104 | <0.001 * |
| ApoB (g/L) | 0.73 ± 0.23 | 1.02 ± 0.41 | −16.500 | <0.001 * |
| ApoB/ApoA | 0.53 ± 0.17 | 0.85 ± 0.52 | −15.068 | <0.001 * |
| Smoking (Yes/No) | (205/557) | (215/489) | 2.368 | 0.124 |
| Drinking (Yes/No) | (70/693) | (64/639) | 0.002 | 0.963 |
| Family history (Yes/No) | (219/545) | (249/463) | 6.770 | 0.009 * |
Abbreviations: BMI, body mass index; WC, waist circumference; HC, hip circumference; WHR, waist-to-hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; TC, total cholesterol; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; FPG, fasting plasma glucose; LPa, lipoprotein(a); ApoA, apolipoprotein A; ApoB, apolipoprotein B; dyslipidemia group vs. normal control group, * p < 0.05; Data represent mean ± SD.